Search

Sucheta D Telang

from Louisville, KY
Age ~56
Get Report
Also known as:
Sucheta Pelang
Related to:
Tushit Jain, 44Vivek Kumar Jain, 43Nipun Jain, 37Pankhuri JainVikas Jain
Connected to:
Ameya Telang, 33Ashwini G Telang, 34Gautam D Telang, 40Madhuri S Telang, 42Rajendra Telang, 66Rajiv A Telang, 49Shreya Telang, 40Smita P Telang, 54Sunil W Telang, 70Alyson Telano, 53

Sucheta Telang Phones & Addresses

  • Louisville, KY
  • Arlington, TX
  • New Britain, CT
  • 7315 Brompton St, Houston, TX 77025
  • Cherry Hill, NJ

Professional Records

License Records

Sucheta D. Telang

Address:
571 S Floyd St SUITE 342, Louisville, KY 40202
Phone:
(502) 852-8470 (Work)
License #:
37099 - Expired
Category:
Neonatal-Perinatal Medicine
Type:
Faculty

Medicine Doctors

Sucheta Telang Photo 1

Sucheta D. Telang

View page
Specialties:
Neonatal-Perinatal Medicine
Work:
University Of Louisville Physicians
503 S Jackson St, Louisville, KY 40202
(502) 852-8470 (phone), (502) 852-8473 (fax)
Education:
Medical School
Lady Hardinge Med Coll, Delhi Univ, New Delhi, Delhi, India
Graduated: 1993
Conditions:
Cleft Palate and Cleft Lip
Complicating Pregnancy or Childbirth
Conditions of Pregnancy and Delivery
Congenital Anomalies of the Heart
Languages:
English
Spanish
Description:
Dr. Telang graduated from the Lady Hardinge Med Coll, Delhi Univ, New Delhi, Delhi, India in 1993. She works in Louisville, KY and specializes in Neonatal-Perinatal Medicine. Dr. Telang is affiliated with Baptist Health Louisville, Norton Hospital and University Of Louisville Hospital.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Sucheta Dinbandhu Telang
Sucheta Telang MD,MBBS,BS
Pediatrician
571 S Floyd St, Louisville, KY 40202
(502) 852-8470

Publications

Us Patents

Pfkfb4 Inhibitors And Methods Of Using The Same

View page
US Patent:
8283332, Oct 9, 2012
Filed:
Apr 16, 2010
Appl. No.:
12/761773
Inventors:
Sucheta Telang - Louisville KY, US
Jason Chesney - Louisville KY, US
Assignee:
University of Louisville Research Foundation, Inc. - Louisville KY
International Classification:
A61K 48/00
US Classification:
514 44R
Abstract:
Methods of reducing expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) and methods of treating a cancer in a cell are provided, the methods including contacting a cell with an effective amount of a PFKFB4 inhibitor. Short hairpin RNA (shRNA) and small interfering RNA (siRNA) inhibitors of PFKFB4 and their methods of use are also provided.

Family Of Pfkfb3 Inhibitors With Anti-Neoplastic Activities

View page
US Patent:
8557823, Oct 15, 2013
Filed:
Nov 30, 2011
Appl. No.:
13/307552
Inventors:
Gilles Tapolsky - Louisville KY, US
Pooran Chand - Birmingham AL, US
John O. Trent - Louisville KY, US
Sucheta Telang - Louisville KY, US
Brian F. Clem - Louisville KY, US
Jason A. Chesney - Louisville KY, US
Assignee:
Advanced Cancer Therapeutics, LLC - Louisville KY
University of Louisville Research Foundation, Inc. - Louisville KY
International Classification:
A01N 43/42
A61K 31/47
A61K 31/497
C07D 215/12
C07D 215/14
US Classification:
51425308, 514311, 514314, 546174
Abstract:
A methods and compounds for inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) are described. Also described are methods of inhibiting cell proliferation, treating cancer, and screening compounds to determine their ability to inhibit PFKFB3.

Family Of Pfkfb3 Inhibitors With Anti-Neoplastic Activities

View page
US Patent:
20090074884, Mar 19, 2009
Filed:
Jun 18, 2008
Appl. No.:
12/141751
Inventors:
Jason Chesney - Louisville KY, US
John O. Trent - Louisville KY, US
Sucheta Telang - Louisville KY, US
Brian Clem - Louisville KY, US
Jason Meier - Louisville KY, US
International Classification:
A61K 33/24
C12N 9/99
C12N 5/08
A61K 31/444
A61P 35/00
C12Q 1/42
A61K 31/4709
A61K 31/44
US Classification:
424649, 435184, 435375, 435377, 514332, 514355, 514314, 435 21
Abstract:
A methods and compounds for inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) are described. Also described are methods of inhibiting cell proliferation, treating cancer, and screening compounds to determine their ability to inhibit PFKFB3.

Small Molecule Choline Kinase Inhibitors, Screening Assays, And Methods For Safe And Effective Treatment Of Neoplastic Disorders

View page
US Patent:
20110212994, Sep 1, 2011
Filed:
Jun 28, 2010
Appl. No.:
12/824680
Inventors:
BRIAN CLEM - LOUISVILLE KY, US
SUCHETA TELANG - LOUISVILLE KY, US
JOHN TRENT - LOUISVILLE KY, US
JASON CHESNEY - LOUISVILLE KY, US
POORAN CHAND - BIRMINGHAM AL, US
GILLES TAPOLSKY - LOUISVILLE KY, US
International Classification:
A61K 31/4709
A61K 31/426
A61K 31/428
A61K 31/427
A61K 31/4196
A61K 31/4166
A61K 31/216
A61K 31/24
A61K 31/165
C07D 401/04
C07D 401/12
C07D 417/12
C07D 277/24
C07D 249/12
C07D 233/78
C07C 323/62
C07C 69/736
C07C 235/34
A61P 35/00
G06G 7/58
US Classification:
514314, 514365, 514367, 514371, 514384, 514389, 514391, 514510, 514534, 514543, 514622, 546167, 546171, 548178, 548195, 548204, 5482644, 5483167, 560 9, 560 61, 564182, 703 11
Abstract:
Small molecule choline kinase inhibitors, pharmaceutical compositions thereof, and screening methods for identifying and evaluating choline kinase inhibitors are provided. Safe and effective methods for treating subjects suffering from a disorder or disease characterized by neoplastic cell proliferation employing the choline kinase inhibitors are also provided.

Small-Molecule Choline Kinase Inhibitors As Anti-Cancer Therapeutics

View page
US Patent:
20110257211, Oct 20, 2011
Filed:
Dec 22, 2010
Appl. No.:
12/975631
Inventors:
Pooran Chand - Birmingham AL, US
Jason A. Chesney - Louisville KY, US
Brian F. Clem - Louisville KY, US
Gilles H. Tapolsky - Louisville KY, US
Sucheta Telang - Louisville KY, US
John O. Trent - Louisville KY, US
Assignee:
ADVANCED CANCER THERAPEUTICS, LLC - Louisville KY
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
International Classification:
A61K 31/506
C07D 417/12
C07D 401/12
C07D 401/04
C07D 403/12
A61P 35/00
A61K 31/427
A61K 31/4439
A61K 31/4709
A61K 31/428
A61K 31/454
C12N 9/99
C07D 249/12
A61K 31/4196
US Classification:
514275, 5482644, 548195, 5462724, 546167, 548163, 544331, 546210, 514383, 514371, 514341, 514314, 514367, 514326, 435184
Abstract:
Small molecule choline kinase inhibitors having the following formula:are provided herein. Also provided herein are pharmaceutical compositions containing Formula I compounds, together with methods of treating cancer, methods of inhibiting choline kinase enzymatic activity, and methods of treating tumors by administering an effective amount of a Formula I compound.

Small Molecule Choline Kinase Inhibitors, Screening Assays, And Methods For Treatment Of Neoplastic Disorders

View page
US Patent:
20130012557, Jan 10, 2013
Filed:
May 12, 2012
Appl. No.:
13/470274
Inventors:
Brian Clem - Louisville KY, US
Sucheta Telang - Louisville KY, US
John Trent - Louisville KY, US
Jason Chesney - Louisville KY, US
Pooran Chand - Birmingham AL, US
Gilles Tapolsky - Louisville KY, US
Assignee:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
International Classification:
A61K 31/4196
A61K 31/216
G06F 19/16
C07C 69/736
C07C 69/157
A61P 35/00
A61K 31/222
C07D 249/12
US Classification:
514384, 514543, 514546, 514510, 5482644, 560 61, 560130, 703 11
Abstract:
Small molecule choline kinase inhibitors, pharmaceutical compositions thereof, and screening methods for identifying and evaluating choline kinase inhibitors are provided. Safe and effective methods for treating subjects suffering from a disorder or disease characterized by neoplastic cell proliferation employing the choline kinase inhibitors are also provided.

Small Molecule Inhibitors Of Pfkfb3 And Glycolytic Flux And Their Methods Of Use As Anti-Cancer Therapeutics

View page
US Patent:
20130059879, Mar 7, 2013
Filed:
Feb 22, 2011
Appl. No.:
13/580558
Inventors:
Pooran Chand - Birmingham AL, US
Jason A. Chesney - Louisville KY, US
Brian F. Clem - Louisville KY, US
Gilles H. Tapolsky - Louisville KY, US
Sucheta Telang - Louisville KY, US
John O. Trent - Louisville KY, US
Assignee:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
ADVANCED CANCER THERAPEUTICS, LLC - Louisville KY
International Classification:
A61K 31/404
C07D 401/06
C12N 5/071
C07D 471/04
A61K 31/4745
A61P 35/00
C07D 209/60
A61K 31/4439
US Classification:
514292, 548427, 514411, 5462767, 514339, 546 84, 546 86, 435375
Abstract:
Small molecule inhibitors of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) having the following formula: Formula (1) are provided herein. Also provided herein are pharmaceutical compositions containing Formula I compounds, together with methods of treating cancer, methods of inhibiting PFK.FB3 enzymatic activity, methods of inhibiting glycolytic flux, and methods of treating tumors by administering an effective amount of a Formula I compound.

Combinations Of Pfkfb3 Inhibitors And Immune Checkpoint Inhibitors To Treat Cancer

View page
US Patent:
20180147198, May 31, 2018
Filed:
May 27, 2016
Appl. No.:
15/576877
Inventors:
- Louisville KY, US
Sucheta TELANG - Louisville KY, US
Kavitha YADDANAPUDI - Louisville KY, US
Assignee:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
International Classification:
A61K 31/4709
A61P 35/00
A61K 39/395
C07K 16/28
A61K 9/00
Abstract:
Provided herein is a method of treating cancer and stimulating anti-tumor immunity in a subject in need thereof, the method including administering to the subject a synergistic, therapeutically effective amount of a PFKFB3 inhibitor, such as PFK-158, in combination with an immune checkpoint inhibitor. Also provided is a method of synergistically increasing activity of an immune checkpoint inhibitor, the method including administering to a subject in need thereof a combination therapy including PFK-158 and the immune checkpoint inhibitor. A pharmaceutical composition including PFK-158, at least one immune checkpoint inhibitor; and at least one pharmaceutically-acceptable carrier is also provided.
Control profile
Sucheta D Telang from Louisville, KY, age ~56 Get Report